- Home
- SDOT vs SYBX Comparison
SDOT vs SYBX Comparison
Compare SDOT & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDOT
- SYBX
- Stock Information
- Founded
- SDOT 2014
- SYBX N/A
- Country
- SDOT United States
- SYBX United States
- Employees
- SDOT N/A
- SYBX N/A
- Industry
- SDOT Restaurants
- SYBX Biotechnology: Pharmaceutical Preparations
- Sector
- SDOT Consumer Discretionary
- SYBX Health Care
- Exchange
- SDOT Nasdaq
- SYBX Nasdaq
- Market Cap
- SDOT 14.2M
- SYBX 16.5M
- IPO Year
- SDOT 2020
- SYBX N/A
- Fundamental
- Price
- SDOT $3.38
- SYBX $1.36
- Analyst Decision
- SDOT Hold
- SYBX Hold
- Analyst Count
- SDOT 1
- SYBX 1
- Target Price
- SDOT N/A
- SYBX N/A
- AVG Volume (30 Days)
- SDOT 28.3K
- SYBX 19.0K
- Earning Date
- SDOT 03-19-2025
- SYBX 03-18-2025
- Dividend Yield
- SDOT N/A
- SYBX N/A
- EPS Growth
- SDOT N/A
- SYBX N/A
- EPS
- SDOT 0.35
- SYBX N/A
- Revenue
- SDOT $655,938,000.00
- SYBX $2,777,000.00
- Revenue This Year
- SDOT $1.20
- SYBX N/A
- Revenue Next Year
- SDOT $29.55
- SYBX N/A
- P/E Ratio
- SDOT $9.70
- SYBX N/A
- Revenue Growth
- SDOT N/A
- SYBX 292.23
- 52 Week Low
- SDOT $2.24
- SYBX $1.22
- 52 Week High
- SDOT $7.00
- SYBX $2.04
- Technical
- Relative Strength Index (RSI)
- SDOT 60.49
- SYBX 45.23
- Support Level
- SDOT $3.01
- SYBX $1.31
- Resistance Level
- SDOT $2.95
- SYBX $1.40
- Average True Range (ATR)
- SDOT 0.19
- SYBX 0.07
- MACD
- SDOT 0.10
- SYBX 0.00
- Stochastic Oscillator
- SDOT 98.85
- SYBX 60.61
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China, and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.